Home Articles & Issues Published Ahead-of-Print CME Collections ABOG MOC II Podcasts Videos Journal Info
Skip Navigation LinksHome > June 2013 - Volume 121 - Issue 6 > A Pharmacologic Approach to the Use of Glyburide in Pregnanc...
Obstetrics & Gynecology:
doi: 10.1097/AOG.0b013e31829007f0
Current Commentary

A Pharmacologic Approach to the Use of Glyburide in Pregnancy

Caritis, Steve N. MD; Hebert, Mary F. PharmD

Cochrane Reviews
Clinical ObGyn
Collapse Box

Abstract

Despite widespread use of glyburide to treat pregnancy-related hyperglycemia, the dosing regimen is based in large part on pharmacokinetic and pharmacodynamic studies in men and nonpregnant women. Like many medications used by pregnant women, adequate pharmacokinetic and pharmacodynamic data in pregnancy have been sorely lacking. This lack of information can lead to both overdosing with excessive side effects and underdosing with an inadequate therapeutic response. Both of these problems may apply to glyburide use in pregnancy. This commentary provides a pharmacologic basis for altering the glyburide administration regimen. Taking glyburide 1 hour before a meal may improve efficacy in patients with pregnancy-related hyperglycemia.

© 2013 The American College of Obstetricians and Gynecologists

Login

Article Tools

Share